Dr. Vikas Dua PRINCIPAL DIRECTOR & HEAD - PEDIATRIC HEMATOLOGY, HEMATO ONCOLOGY & BONE MARROW TRANSPLANT

About Dr. Vikas Dua

Dr. Vikas Dua is the Principal Director and Head of the Department of Paediatric Haematology, Hemato-Oncology and Bone Marrow Transplant at Fortis Memorial Research Institute, Gurugram — one of India’s leading centres for blood cancers and transplant medicine in children and young adults.

With decades of experience in paediatric haematology and bone marrow transplantation, Dr. Dua is widely recognised as one of India’s foremost specialists in treating leukaemia, lymphoma, aplastic anaemia, thalassaemia, and other serious blood disorders in children. He completed his specialisation from premier Indian medical institutions and has additional training from internationally recognised transplant centres.

Fortis Memorial Research Institute’s BMT unit under Dr. Dua’s leadership has performed hundreds of bone marrow transplants with outcome rates comparable to the world’s best centres. The unit is equipped for allogeneic, autologous, and haploidentical transplants — offering options for patients who do not have a fully matched donor.

Conditions Treated

Consult Dr. Vikas Dua, Head of Bone Marrow Transplant at Fortis Memorial Gurugram specialises in the diagnosis and treatment of:

• Acute Lymphoblastic Leukaemia (ALL) in children
• Acute Myeloid Leukaemia (AML) in children and young adults
• Allogeneic Bone Marrow Transplant — matched sibling and unrelated donor
• Autologous Bone Marrow Transplant
• Haploidentical Transplant — for patients without fully matched donors
• Aplastic Anaemia — severe and very severe forms
• Thalassaemia Major — curative transplant option
• Sickle Cell Disease — transplant evaluation and management
• Non-Hodgkin Lymphoma in children

Immune Deficiency Disorders requiring transplantation

Why Kazakhstan & CIS Patients Choose Dr. Vikas Dua

For families from Kazakhstan, Russia, and Uzbekistan facing a childhood leukaemia or aplastic anaemia diagnosis, bone marrow transplant in India represents a life-saving option at a fraction of the cost of Western countries.

Bone marrow transplant cost in India: $18,000 to $28,000 USD for allogeneic transplant. The same procedure in Germany or the USA costs $80,000 to $150,000. In Kazakhstan, access to paediatric BMT is limited, and waiting times can be prohibitive for conditions that require urgent treatment.

Dr. Vikas Dua — Paediatric Haematology & BMT Specialist, Fortis Gurugram has successfully treated children from CIS countries. MediKaya Healthcare provides dedicated Russian-speaking support for every family, ensuring that parents and caregivers are guided through every step of what is a deeply personal and challenging journey.

Experience Overview

• Dr. Vikas Dua has over 15 years of experience in the field of Paediatric Hematology Oncology and Bone Marrow Transplant (BMT).
• He has successfully performed more than 1000 stem cell and bone marrow transplants, with excellent clinical outcomes, especially in paediatric unrelated and haploidentical transplants.
• Dr. Vikas Dua, Fortis Memorial Research Institute, Gurugram is known for conducting several rare and complex transplants that have been done for the first time in India.
• He has previously worked at Sir Ganga Ram Hospital, where he completed his fellowship and contributed significantly to the paediatric BMT program.
• Currently, he practices at a leading hospital in Delhi NCR, where he leads the paediatric BMT unit and continues to set new benchmarks in treatment success rates.

Professional Memberships

Languages Spoken

• English
• Hindi
• Punjabi

Frequently Asked Questions

Q: What is the cost of bone marrow transplant for a child in India?

A: Bone marrow transplant at Fortis Memorial Gurugram under Dr. Vikas Dua’s supervision costs approximately $18,000 to $28,000 USD for an allogeneic transplant (matched sibling or unrelated donor). Autologous transplant costs approximately $12,000 to $16,000. These figures include pre-transplant workup, the procedure, hospital stay of 4 to 6 weeks, and post-transplant monitoring.

Q: Can a child from Kazakhstan with leukaemia come to India for treatment?

A: Yes. Fortis Memorial Research Institute has a dedicated international patient programme. Dr. Vikas Dua’s team accepts referrals from Kazakhstan and across the CIS. Send the child’s diagnosis reports, bone marrow biopsy results, and cytogenetic reports to MediKaya Healthcare for a free specialist review.

Q: What is the success rate of bone marrow transplant at Fortis Memorial?

A: Fortis Memorial Research Institute reports 5-year disease-free survival rates of 65 to 75 per cent for paediatric ALL and 55 to 65 per cent for AML following allogeneic BMT — figures comparable to leading transplant centres globally. Success rates depend on disease type, stage, donor matching, and patient’s pre-transplant condition.

Q: What if a suitable bone marrow donor is not available in our family?

A: Dr. Vikas Dua’s team is highly experienced in haploidentical transplant — a procedure using a partially matched related donor (parent, sibling, or child). This option is available for patients who do not have a fully matched sibling or unrelated donor, significantly expanding transplant eligibility.

Q: How long does a bone marrow transplant patient need to stay in India?

A: The typical stay for a bone marrow transplant patient is 8 to 12 weeks — including pre-transplant conditioning, the transplant procedure, and initial recovery. The post-transplant monitoring period is critical, and our team coordinates with local haematologists in your home country for ongoing care after return.